Is Precision BioSciences, Inc. (DTIL) a Buy, Sell, or Hold?
NASDAQ : DTIL
Precision BioSciences, Inc. — Insider Trades
$7.49 USD
$0.07 (0.94%)
- Volume
- 239.58K
- Average Volume
- 410.88K
- Market Capitalization
- $96.08M
- P/E Ratio
- -2.68
- Dividend Yield
- 0.00%
- Price Target
- $19.50
- Year High
- $9.62
- Year Low
- $3.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $12.82
Insider Activity Summary (Last 12 Months)
Insiders Buying
32
Insiders Selling
35
Amount of Insider Selling
$575.82K
DTIL Insider Buying/Selling by Quarter
DTIL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Gorsuch Cassandra Louise | officer: Chief Scientific Officer | 2026-08-01 | 0 | 2026-08-03 | |
| Gorsuch Cassandra Louise | officer: Chief Scientific Officer | 2026-08-01 | 36 | 2026-08-03 | |
| Gorsuch Cassandra Louise | officer: Chief Scientific Officer | 2026-08-01 | 359.4 | 2026-08-03 | |
| Gorsuch Cassandra Louise | officer: Chief Scientific Officer | 2026-08-01 | 0 | 2026-08-03 | |
| Burris Mei Zhang Lu | officer: Chielf Accounting Officer | 2026-08-01 | 0 | 2026-08-03 | |
| Burris Mei Zhang Lu | officer: Chielf Accounting Officer | 2026-08-01 | 378 | 2026-08-03 | |
| Burris Mei Zhang Lu | officer: Chielf Accounting Officer | 2026-08-01 | 174.9 | 2026-08-03 | |
| Burris Mei Zhang Lu | officer: Chielf Accounting Officer | 2026-08-01 | 340.2 | 2026-08-03 | |
| Burris Mei Zhang Lu | officer: Chielf Accounting Officer | 2026-08-01 | 122.4 | 2026-08-03 | |
| Burris Mei Zhang Lu | officer: Chielf Accounting Officer | 2026-08-01 | 0 | 2026-08-03 | |
| Tanna Naresh Haresh | officer: Chief Financial Officer | 2026-08-01 | 0 | 2026-08-03 | |
| Tanna Naresh Haresh | officer: Chief Financial Officer | 2026-08-01 | 0 | 2026-08-03 | |
| Brown Melinda | director | 2026-06-03 | A-Award | 0 | 2026-06-05 |
| Frankel Stanley | director | 2026-06-03 | A-Award | 0 | 2026-06-05 |
| Germano Geno J | director | 2026-06-03 | A-Award | 0 | 2026-06-05 |
| Pire Shari Lisa | director | 2026-06-03 | A-Award | 0 | 2026-06-05 |
| Buehler Kevin | director | 2026-06-03 | A-Award | 0 | 2026-06-05 |
| Buehler Kevin | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Buehler Kevin | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Frankel Stanley | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Frankel Stanley | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Brown Melinda | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Brown Melinda | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Pire Shari Lisa | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Pire Shari Lisa | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Germano Geno J | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Germano Geno J | director | 2026-05-20 | M-Exempt | 0 | 2026-05-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| Amoroso Michael | director, officer: President and CEO | 2026-02-18 | S-Sale | 3.84 | 2026-02-19 |
| Amoroso Michael | director, officer: President and CEO | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-02-18 | S-Sale | 3.84 | 2026-02-19 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-02-18 | S-Sale | 3.84 | 2026-02-19 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-02-18 | S-Sale | 3.84 | 2026-02-19 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-02-17 | M-Exempt | 0 | 2026-02-19 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-22 | S-Sale | 4.17 | 2026-01-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Amoroso Michael | director, officer: President and CEO | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-21 | S-Sale | 4.03 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Scimeca Dario | officer: General Counsel and Secretary | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-21 | S-Sale | 4.03 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Kelly John Alexander | officer: Chief Financial Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-21 | M-Exempt | 0 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-21 | S-Sale | 4.03 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2026-01-20 | M-Exempt | 0 | 2026-01-22 |
| Germano Geno J | director | 2025-12-16 | P-Purchase | 4.72 | 2025-12-17 |
| Frankel Stanley | director | 2025-12-16 | P-Purchase | 4.7 | 2025-12-17 |
| Brown Melinda | director | 2025-12-15 | P-Purchase | 4.97 | 2025-12-17 |
| Kelly John Alexander | officer: Chief Financial Officer | 2025-11-02 | M-Exempt | 0 | 2025-11-04 |
| Kelly John Alexander | officer: Chief Financial Officer | 2025-11-03 | S-Sale | 6.49 | 2025-11-04 |
| Kelly John Alexander | officer: Chief Financial Officer | 2025-11-02 | M-Exempt | 0 | 2025-11-04 |
| Scimeca Dario | officer: General Counsel and Secretary | 2025-11-02 | M-Exempt | 0 | 2025-11-04 |
| Scimeca Dario | officer: General Counsel and Secretary | 2025-11-03 | S-Sale | 6.49 | 2025-11-04 |
| Scimeca Dario | officer: General Counsel and Secretary | 2025-11-02 | M-Exempt | 0 | 2025-11-04 |
| Amoroso Michael | director, officer: President and CEO | 2025-11-02 | M-Exempt | 0 | 2025-11-04 |
| Amoroso Michael | director, officer: President and CEO | 2025-11-03 | S-Sale | 6.49 | 2025-11-04 |
| Amoroso Michael | director, officer: President and CEO | 2025-11-03 | M-Exempt | 0 | 2025-11-04 |
| Frankel Stanley | director | 2025-09-26 | P-Purchase | 4.97 | 2025-09-30 |
| Brown Melinda | director | 2025-09-22 | P-Purchase | 4.89 | 2025-09-24 |
| Kelly John Alexander | officer: Chief Financial Officer | 2025-07-03 | S-Sale | 4.26 | 2025-07-08 |
| Brown Melinda | director | 2025-06-25 | P-Purchase | 4.14 | 2025-06-27 |
| Buehler Kevin | director | 2025-06-25 | P-Purchase | 4.16 | 2025-06-27 |
| Germano Geno J | director | 2025-06-03 | A-Award | 0 | 2025-06-04 |
| Germano Geno J | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Germano Geno J | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Pire Shari Lisa | director | 2025-06-03 | A-Award | 0 | 2025-06-04 |
| Pire Shari Lisa | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Pire Shari Lisa | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Frankel Stanley | director | 2025-06-03 | A-Award | 0 | 2025-06-04 |
| Frankel Stanley | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Frankel Stanley | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Buehler Kevin | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Buehler Kevin | director | 2025-06-03 | A-Award | 0 | 2025-06-04 |
| Buehler Kevin | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Brown Melinda | director | 2025-06-03 | A-Award | 0 | 2025-06-04 |
| Brown Melinda | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| Brown Melinda | director | 2025-05-27 | M-Exempt | 0 | 2025-06-04 |
| SMITH J. JEFFERSON | officer: Chief Research Officer | 2025-06-02 | A-Award | 0 | 2025-06-04 |